Available vaccines, licensing status, prequalification status, presentation, formulation, dosage and route of administration

Thre are currently 7 HPV vaccines with marketing authorisation include Bivalent: Cecolin ®, Cervarix ®, Walrinvax ®; Quadrivalent: Gardasil ® , Cervavac; Nonavalent: Gardasil-9 ®, Cecolin 9® of which 5 prequalified. Go to footnote 1

Sources